Morgan Stanley Initiates Coverage on Heartflow (NASDAQ:HTFL)

Key Points

• Morgan Stanley initiated coverage on Heartflow (NASDAQ:HTFL) with an "equal weight" rating and a target price of $35.00, indicating an expected upside of 11.11% from the current price.
• Multiple analysts, including Canaccord Genuity and JPMorgan Chase, have issued various ratings for Heartflow, with the consensus rating currently being "Moderate Buy" and an average target price of $35.80.
• Heartflow's stock opened at $31.50 and has a 12-month price range between $26.56 and $36.68.

Morgan Stanley initiated coverage on shares of Heartflow (NASDAQ:HTFL - Free Report) in a research note issued to investors on Tuesday, MarketBeat Ratings reports. The firm issued an equal weight rating and a $35.00 price target on the stock.

Other analysts have also recently issued research reports about the stock. Piper Sandler started coverage on shares of Heartflow in a research note on Tuesday. They issued an "overweight" rating and a $38.00 price objective for the company. Stifel Nicolaus started coverage on shares of Heartflow in a research note on Tuesday. They issued a "buy" rating and a $35.00 price objective for the company. JPMorgan Chase & Co. started coverage on shares of Heartflow in a research note on Tuesday. They issued an "overweight" rating and a $36.00 price objective for the company. Wall Street Zen upgraded shares of Heartflow to a "hold" rating in a research note on Saturday, August 16th. Finally, Canaccord Genuity Group started coverage on shares of Heartflow in a research note on Tuesday. They issued a "buy" rating and a $35.00 price objective for the company. Four research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $35.80.

Heartflow Stock Performance

Shares of NASDAQ HTFL traded down $3.01 during mid-day trading on Tuesday, reaching $31.07. 442,043 shares of the company were exchanged, compared to its average volume of 878,154. Heartflow has a twelve month low of $26.56 and a twelve month high of $36.68.

About Heartflow

We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.